Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for 5 fu
Most Correlated Studies
- Pancreatic carcinoma Fluorouracil (5-FU) resistant and sensitive cell lines
- Evi1 Retroviral Transduction Of 5-FU-Primed Bone Marrow Cells
- Response to neoadjuvant chemo (5-FU, epirubicin, cyclophosphamide) and resection in breast cancer
- Erythroblasts from spleen of mice with Nfe2l2 + MIR144 + MIR145 triple knockout treated with 5-FU
- Gastric cancer PDX tumors from nude mice on FOLFOX (leucovorin + 5-FU + oxaliplatin) regimen
Most Relevant Literature
- Binding Pattern and Structural Interactome of the Anticancer Drug 5-Fluorouracil: A Critical Review.
- Intralesional 5-Fluorouracil for Keloids: A Systematic Review.
- 5-Fluorouracil-induced leukoencephalopathy.
- The advancing of polymeric core-shell ZnO nanocomposites containing 5-fluorouracil for improving ant…
- Innovative Strategies to Combat 5-Fluorouracil Resistance in Colorectal Cancer: The Role of Phytoche…
Most Relevant Clinical Trials
- Retrospective Evaluation of 5-FU Exposure Optimization in CRC Patients
- Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas
- A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC)
- P2 5-FU, Oxaliplatin & Liposomal Irinotecan (Nal-IRI) in 1st Line Advanced Esophageal & Gastric
- ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With Leucovorin
